222 related articles for article (PubMed ID: 35709179)
21. Clinical and pathological features and the BRAF(V600E) mutation in patients with papillary thyroid carcinoma with and without concurrent Hashimoto thyroiditis.
Kim SK; Song KH; Lim SD; Lim YC; Yoo YB; Kim JS; Hwang TS
Thyroid; 2009 Feb; 19(2):137-41. PubMed ID: 19014278
[TBL] [Abstract][Full Text] [Related]
22. Clinical relationship between Hashimoto's thyroiditis and papillary thyroid cancer.
Ahn D; Heo SJ; Park JH; Kim JH; Sohn JH; Park JY; Park SK; Park J
Acta Oncol; 2011 Nov; 50(8):1228-34. PubMed ID: 21871002
[TBL] [Abstract][Full Text] [Related]
23. Risk of lymph node metastases in multifocal papillary thyroid cancer associated with Hashimoto's thyroiditis.
Konturek A; Barczyński M; Nowak W; Wierzchowski W
Langenbecks Arch Surg; 2014 Feb; 399(2):229-36. PubMed ID: 24407910
[TBL] [Abstract][Full Text] [Related]
24. [Clinical and pathological differences between papillary thyroid carcinoma with Graves' disease and papillary thyroid carcinoma with Hashimoto's thyroiditis].
Xu DD; Lun Y; Liu X; Jiang H; Song JB; Duan ZQ; Xin SJ; Zhang J
Zhonghua Yi Xue Za Zhi; 2017 Aug; 97(32):2491-2495. PubMed ID: 28835054
[No Abstract] [Full Text] [Related]
25. Bilaterality weighs more than unilateral multifocality in predicting prognosis in papillary thyroid cancer.
Qu N; Zhang L; Wu WL; Ji QH; Lu ZW; Zhu YX; Lin DZ
Tumour Biol; 2016 Jul; 37(7):8783-9. PubMed ID: 26743781
[TBL] [Abstract][Full Text] [Related]
26. Does papillary thyroid carcinoma have a better prognosis with or without Hashimoto thyroiditis?
Kwak HY; Chae BJ; Eom YH; Hong YR; Seo JB; Lee SH; Song BJ; Jung SS; Bae JS
Int J Clin Oncol; 2015 Jun; 20(3):463-73. PubMed ID: 25312294
[TBL] [Abstract][Full Text] [Related]
27. Pathologic spectrum of lymphocytic infiltration and recurrence of papillary thyroid carcinoma.
Kim HG; Kim EK; Han KH; Kim H; Kwak JY
Yonsei Med J; 2014 Jul; 55(4):879-85. PubMed ID: 24954314
[TBL] [Abstract][Full Text] [Related]
28. Thyroid cancer associated with Hashimoto thyroiditis: similarities and differences in an endemic area.
Hussein O; Abdelwahab K; Hamdy O; Awny S; Megahed NA; Hafez MT; Elalfi AF; Abdelaziz M; Gaballah K; Abdelkhalek M
J Egypt Natl Canc Inst; 2020 Jan; 32(1):7. PubMed ID: 32372240
[TBL] [Abstract][Full Text] [Related]
29. Well-differentiated thyroid carcinoma with concomitant Hashimoto's thyroiditis present with less aggressive clinical stage and low recurrence.
Huang BY; Hseuh C; Chao TC; Lin KJ; Lin JD
Endocr Pathol; 2011 Sep; 22(3):144-9. PubMed ID: 21647844
[TBL] [Abstract][Full Text] [Related]
30. The Effects of Chronic Lymphocytic Thyroiditis on Clinicopathologic Factors in Papillary Thyroid Cancer.
Sakiz D; Sencar ME; Calapkulu M; Ozturk Unsal I; Aktas L; Ucan B; Ozbek M; Cakal E
Endocr Pract; 2021 Dec; 27(12):1199-1204. PubMed ID: 34293511
[TBL] [Abstract][Full Text] [Related]
31. Hashimoto's thyroiditis, microcalcification and raised thyrotropin levels within normal range are associated with thyroid cancer.
Ye ZQ; Gu DN; Hu HY; Zhou YL; Hu XQ; Zhang XH
World J Surg Oncol; 2013 Mar; 11():56. PubMed ID: 23496874
[TBL] [Abstract][Full Text] [Related]
32. Risk and Prognostic Factors for BRAF
Wei X; Wang X; Xiong J; Li C; Liao Y; Zhu Y; Mao J
Biomed Res Int; 2022; 2022():9959649. PubMed ID: 35647194
[TBL] [Abstract][Full Text] [Related]
33. Programmed Death-Ligand 1 Expression in Papillary Thyroid Cancer and Its Correlation with Clinicopathologic Factors and Recurrence.
Shi RL; Qu N; Luo TX; Xiang J; Liao T; Sun GH; Wang Y; Wang YL; Huang CP; Ji QH
Thyroid; 2017 Apr; 27(4):537-545. PubMed ID: 27825291
[TBL] [Abstract][Full Text] [Related]
34. Significance of multifocality in papillary thyroid carcinoma.
Feng JW; Qu Z; Qin AC; Pan H; Ye J; Jiang Y
Eur J Surg Oncol; 2020 Oct; 46(10 Pt A):1820-1828. PubMed ID: 32732090
[TBL] [Abstract][Full Text] [Related]
35. Chronic lymphocytic thyroiditis protects against recurrence in patients with cN0 papillary thyroid cancer.
Ryu YJ; Yoon JH
Surg Oncol; 2020 Sep; 34():67-73. PubMed ID: 32891356
[TBL] [Abstract][Full Text] [Related]
36. The clinical features of papillary thyroid cancer in Hashimoto's thyroiditis patients from an area with a high prevalence of Hashimoto's disease.
Zhang L; Li H; Ji QH; Zhu YX; Wang ZY; Wang Y; Huang CP; Shen Q; Li DS; Wu Y
BMC Cancer; 2012 Dec; 12():610. PubMed ID: 23256514
[TBL] [Abstract][Full Text] [Related]
37. An Evaluation of Clinicopathological Factors Effective in the Development of Central and Lateral Lymph Node Metastasis in Papillary Thyroid Cancer.
Aydin Buyruk B; Kebapci N; Yorulmaz G; Buyruk A; Kebapci M
J Natl Med Assoc; 2018 Aug; 110(4):384-390. PubMed ID: 30126565
[TBL] [Abstract][Full Text] [Related]
38. Coexistence of papillary thyroid cancer with Hashimoto thyroiditis.
Konturek A; Barczyński M; Wierzchowski W; Stopa M; Nowak W
Langenbecks Arch Surg; 2013 Mar; 398(3):389-94. PubMed ID: 23099542
[TBL] [Abstract][Full Text] [Related]
39. Sonographic features of primary tumor as independent predictive factors for lymph node metastasis in papillary thyroid carcinoma.
Wu Q; Li Y; Wang Y; Hu B
Clin Transl Oncol; 2015 Oct; 17(10):830-4. PubMed ID: 26041723
[TBL] [Abstract][Full Text] [Related]
40. Preoperatively Predicting the Central Lymph Node Metastasis for Papillary Thyroid Cancer Patients With Hashimoto's Thyroiditis.
Min Y; Huang Y; Wei M; Wei X; Chen H; Wang X; Chen J; Xiang K; Feng Y; Yin G
Front Endocrinol (Lausanne); 2021; 12():713475. PubMed ID: 34367075
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]